TRPV1 activation has been linked by several studies to an anti-tumour effect in breast cancer, where it promotes cell death and may reduce cell proliferation, and TRPV1 channel agonists may have a therapeutic effect (Nur et al., 2017; Nazıroğlu et al., 2017). This evidence concerns the gene TRPV1 and breast carcinoma.